Virtual Reality in Awake Surgery : Pilot Study VIRAS
VIRAS
1 other identifier
interventional
50
1 country
1
Brief Summary
The VIRAS (Virtual Reality in Awake Surgery) project is a two-stage, adaptive study. Its goal is to demonstrate the tolerance of the virtual reality (VR) headset for performing cognitive neuro-monitoring during awake brain surgery. Awake surgery involves operating on patients who remain conscious during the procedure and is most commonly employed in interventions such as tumor resections and epilepsy treatments. This approach allows surgeons to monitor and preserve critical brain functions by engaging the patient in real-time assessments of motor, sensory, and cognitive capabilities. The use of immersive distractions such as VR can help reduce anxiety and discomfort during awake craniotomy. In order to control the risks as well as possible, the investigators have tested the equipment on patients who will undergo orthopedic surgery under local anesthesia at the hospital of Brest (Saliou V, Dardenne G, Panheleux C, Le Vourc'h F, Bleunven J, Maoudj I, Longo B, Dubrana F, Yvinou A, Fernandez M, Consigny M, Nowak E, Guellec D, Seizeur R. Virtual Reality in Awake brain Surgery (VIRAS) stage I: Proof of concept and tolerance validation during scheduled orthopedic surgery. PLoS One. 2025 Sep 3;20(9):e0329894. doi: 10.1371/journal.pone.0329894. PMID: 40901801; PMCID: PMC12407469.) The second part of the project; the equipment is tested on patients wich undergo neurosurgery in awake condition, using the same equipment and procedures as in the orthopedic cohort. An additional element will be the integration of a dedicated software application for the selection and control of neurofunctional tests. This application relies on an algorithm that incorporates both lesion laterality and tumor location, enabling dynamic adaptation of the test sequence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable surgery
Started May 2022
Longer than P75 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2021
CompletedFirst Posted
Study publicly available on registry
December 9, 2021
CompletedStudy Start
First participant enrolled
May 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
May 18, 2026
May 1, 2026
4.9 years
November 8, 2021
May 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tolerance of minimum 1 hour of the virtual reality mask (realization, by the patient, of a series of of language or neuropsychological tests)
Study the tolerance of the virtual reality mask on patients in the operating room for orthopedic surgery under loco-regional anesthesia. The mask must be maintained during the testing (minimum 1 hour). The testing consists in the realization, by the patient, of a series of language or neuropsychological tests predefined during the preoperative assessment.
1 Day
Secondary Outcomes (18)
Device-related adverse event
1 Day
Withdrawal of the device
1 Day
Device tolerance for the patient
1 Day
Device tolerance for the medical staff
1 Day
Patient state of anxiety
1 Day
- +13 more secondary outcomes
Study Arms (1)
Virtual reality mask
EXPERIMENTALRealization of the following examinations with virtual reality mask : * Training session * Acceptability of the device before and after surgery * Monitoring of the device during surgery
Interventions
Patients will have a training session with the virtual reality mask, the day before surgery. The training consists in the realization, by the patient, of a series of language or neuropsychological tests and evaluation of the acceptability of the device by the patient with Visual Analog Scale (device tolerance from 0 (intolerable) to 10 (completely tolerated)).
In the operating room : installation and per-operative monitoring of the device. If the device was removed, the list of device side effects or surgery-related adverse events that was required discontinuation of the device will be established.
After the surgery: evaluation of the acceptability of the device by the patient with Visual Analog Scale (device tolerance from 0 (intolerable) to 10 (completely tolerated))
Assessing patient's state of anxiety with the State-Trait Anxiety Inventory (STAI) after surgery.
Eligibility Criteria
You may qualify if:
- Major subject
- Consent for the study
- Patients eligible for orthopedic surgery with local anesthetic block
- Estimated duration of the Orthopedic surgery of minimum 1 hour
- For neurosurgical patients in a awake state : Patients eligible for awake neurosurgery (multidisciplinary decision: neurosurgeon, neurologist, oncologist, radiation therapist, anesthesiologist, after psychological, neuropsychological, and speech therapy evaluation)
You may not qualify if:
- Age \< 18 years, Age \> 75 years,
- Known central neurological pathology/cognitive impairment,
- Mini-Mental State examination (MMSe) \< 23 if no school certificate, \< 27 if school certificate,
- History of vertigo,
- Claustrophobia,
- Visual deficit not compatible with the use of the virtual reality mask,
- Contraindication to surgery,
- Outpatient treatment,
- Refusal or inability to consent.
- For neurosurgical patients in a awake state : Psychological/psychiatric contraindications to awake surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pr SEIZEUR Romuald
Brest, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2021
First Posted
December 9, 2021
Study Start
May 24, 2022
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
May 18, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available after the publication of result and ending 15 years following the last visit of the last patient.
- Access Criteria
- Data access requests will b reviewed be the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication